Pages that link to "Q35704086"
Jump to navigation
Jump to search
The following pages link to Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine Papillomavirus-HIV-1 gp41 chimeric virus-like particles (Q35704086):
Displaying 29 items.
- Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection (Q26775082) (← links)
- Emerging Vaccine Technologies (Q26783764) (← links)
- Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41 (Q27312171) (← links)
- Elicitation of structure-specific antibodies by epitope scaffolds (Q27664711) (← links)
- Structure-Based Design of a Protein Immunogen that Displays an HIV-1 gp41 Neutralizing Epitope (Q27675260) (← links)
- Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review (Q30404393) (← links)
- Mimotopes selected with antibodies from HIV-1-neutralizing long-term non-progressor plasma (Q33269695) (← links)
- Broad neutralization of human immunodeficiency virus type 1 (HIV-1) elicited from human rhinoviruses that display the HIV-1 gp41 ELDKWA epitope (Q33417195) (← links)
- Heterologous epitope-scaffold prime:boosting immuno-focuses B cell responses to the HIV-1 gp41 2F5 neutralization determinant (Q33812812) (← links)
- Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination (Q34075698) (← links)
- A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1 (Q34396912) (← links)
- Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response. (Q34540352) (← links)
- In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10. (Q35947769) (← links)
- Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external region (Q36372534) (← links)
- Antigenicity and Immunogenicity in HIV-1 Antibody-Based Vaccine Design (Q36447540) (← links)
- The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design (Q36497712) (← links)
- Engineering Recombinant Reoviruses To Display gp41 Membrane-Proximal External-Region Epitopes from HIV-1 (Q36956100) (← links)
- Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure (Q36978277) (← links)
- Development of prophylactic vaccines against HIV-1. (Q37042563) (← links)
- Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state (Q37250899) (← links)
- Role of lipid structure in the humoral immune response in mice to covalent lipid-peptides from the membrane proximal region of HIV-1 gp41. (Q37316019) (← links)
- Bovine papillomavirus-like particles presenting conserved epitopes from membrane-proximal external region of HIV-1 gp41 induced mucosal and systemic antibodies (Q37438127) (← links)
- Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus (Q38635840) (← links)
- Enhancing efficacy and mucosa-tropic distribution of an oral HIV-PsV DNA vaccine in animal models (Q39013219) (← links)
- Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1. (Q40721814) (← links)
- A comparative study of the adjuvanticity of Hansenula polymorpha, Saccharomyces cerevsiae and Yarrowia lipolytica in oral and nasal immunization with virus capsid antigens (Q42288129) (← links)
- Increased sensitivity of HIV variants selected by attachment inhibitors to broadly neutralizing antibodies (Q43095098) (← links)
- Expression and immunological characterization of cardamom mosaic virus coat protein displaying HIV gp41 epitopes (Q45351263) (← links)
- Characterization of HIV-1 gp120 antibody specificities induced in anogenital secretions of RV144 vaccine recipients after late boost immunizations. (Q52558317) (← links)